Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023)
Exelixis (EXEL) recorded Non-Current Deffered Revenue of $6.72 million in Q2 2023, down 6.7% from $7.21 million a year earlier but up 6.7% from the prior quarter.
Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023) Analysis & Trends
At the end of FY2022, Exelixis reported Non-Current Deffered Revenue of $6.58 million, down 24.7% from FY2021.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -51.2% (FY2017 to FY2022).
- Across earlier years, Non-Current Deffered Revenue came in at $8.74 million in FY2021 (+132.7%), $3.76 million in FY2020 and $15.9 million in FY2018 (-93.3%).
- Quarterly Non-Current Deffered Revenue has ranged from $2.27 million in Q3 2018 to $15.9 million in Q4 2018 over the past five years.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for six consecutive quarters, with growth averaging 2.1% over the last seven quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 132.7% in Q4 2021, against a decline of 93.3% in Q4 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.3 million (Q1 2023), $6.58 million (Q4 2022) and $6.49 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 6.30 Mn |
| Dec 30, 2022 | 6.58 Mn |
| Sep 30, 2022 | 6.49 Mn |
| Jul 1, 2022 | 7.21 Mn |
| Apr 1, 2022 | 8.04 Mn |
| Dec 31, 2021 | 8.74 Mn |
| Oct 1, 2021 | 9.44 Mn |
| Jul 2, 2021 | 8.58 Mn |
| Apr 2, 2021 | 9.76 Mn |
| Jan 1, 2021 | 3.76 Mn |
| Oct 2, 2020 | 9.32 Mn |
| Jul 3, 2020 | 15.00 Mn |
| Apr 3, 2020 | 14.13 Mn |
| Jan 3, 2020 | 6.60 Mn |
| Sep 27, 2019 | 15.40 Mn |
| Jun 28, 2019 | 16.63 Mn |
| Mar 29, 2019 | 8.32 Mn |
| Dec 28, 2018 | 15.90 Mn |
| Sep 28, 2018 | 2.27 Mn |
Exelixis Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EXEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();